mPharma, a Ghanaian based pharmaceutical services company, says as Ghana battle the spread of COVID-19, it is looking to address what may be a potential drug supply shortage and price increases due to ongoing disruptions in the drug supply chains globally caused by the outbreak of Coronavirus.
